Newly-released Hospital-acquired Infection Control Market analysis report by Future Market Insights shows that global sales of Hospital-acquired Infection Control in 2023 were held at US$ 6.5 Billion. With a CAGR of 7% from 2023 to 2033, the market is projected to reach US$ 12.7 Billion by 2033. The market is expected to generate significant revenue through Hospitals and Intensive care Units, accounting for a CAGR of 7.6%.
| Attribute | Details |
|---|---|
| Global Hospital-Acquired Infection Control Market (2023) | US$ 6.5 Billion |
| Global Hospital-Acquired Infection Control Market (2033) | US$ 12.7 Billion |
| Global Hospital-Acquired Infection Control Market CAGR (2023 to 2033) | 7% |
| USA Hospital-Acquired Infection Control Market CAGR (2023 to 2033) | 8.1% |
| Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Hospital-acquired Infection Control industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value of the Hospital-acquired Infection Control market increased at a CAGR of 6.5%, wherein, countries such as the USA, the United kingdom, China, South Korea and Japan held significant share in the global market. Owing to this, the market is projected to grow at a CAGR of 7.6% over the coming 10 years.
The frequent occurrence of hospital-acquired infections, the growing proportion of surgical procedures, the rising geriatric population and the increasing prevalence of chronic diseases, technological advancements in sterilization equipment, and the growing awareness of environmental and personal hygiene are the key factors driving the growth of the Hospital-acquired infection control market.
The growing use of e-beam sterilization and the reintroduction of ethylene oxide sterilization are further expected to swell the demand for hospital-acquired infection control.
The percentage of surgeries performed worldwide has increased significantly over the years. Every year, approximately 235 million complex surgical procedures are performed worldwide, according to the WHO. This is due to an increase in the prevalence of obesity and other lifestyle diseases, an increase in the geriatric population, and an increase in the incidence of spinal injuries and sports-related injuries.
With the growth in the number of surgical procedures conducted, the demand for various surgical equipment and medical devices is also surging. The proven benefits of sterilized product lines and growing awareness about their effectiveness in healthcare settings are expected to drive demand for hospital-acquired infection services.
Ethylene oxide is one of the most effective gaseous sterilizing agents for high-temperature-sensitive instruments, such as plastic equipment and instruments with electrical components. The CDC, on the other hand, has stated that chronic exposure to ethylene oxide in the workplace can cause cancer. Furthermore, ethylene oxide sterilization can irritate the skin and mucous membranes, causing CNS abnormalities in humans.
Acute exposure to EtO gas, on the other hand, can cause respiratory irritation, lung injury, headache, nausea, vomiting, diarrhea, shortness of breath, and cyanosis. EtO degrades in the atmosphere as well, reacting with photochemically generated hydroxyl radicals. Regulatory frameworks have been established in several countries to govern the use of EtO in specific sterilization applications.
Principal Consultant
Due to rising demand for Hospital-acquired Infection Control methods in developing nations, particularly Japan, the market in the Asia Pacific is projected to account for a CAGR of over 7% during the forecast period.
The regional market is growing due to the extensive usage of Hospital-acquired infection controls and increased awareness of general health and fitness among the working-class population.
The USA stands as one of the largest markets for hospital-acquired infection control. The market growth in the region is characterized by rising demand for and adoption of sterilization and disinfection products and services as a result of consumers' increased emphasis on healthy lifestyles and disease prevention.
The increase in the geriatric population in the coming years, as well as the subsequent rise in the incidence of chronic diseases, the need for Hospital-acquired infection control to reduce the prevalence of HAIs, and the implementation of favorable government initiatives and stringent sterilization and disinfection regulations, are driving the Hospital-acquired infection market in the country.
The market in the United kingdom is expected to reach a valuation of US$ 527 Million by 2033. Growing with a CAGR of 5.8% in the forecast period, the market in the country is projected to garner an absolute dollar opportunity of around US$ 227.7 Million.
In Japan, the market is expected to grow at a CAGR of 6.8% from 2023 to 2033, reaching around US$ 490.6 Million by 2033. The market in the country is expected to gross an absolute dollar opportunity of US$ 238 Million during the forecast period.
The market in South Korea is expected to reach a valuation of around US$ 262 Million by 2033, growing at a CAGR of 6.6% from 2023 to 2033. The market in the country is expected to witness an absolute dollar opportunity of around US$ 123.7 Million.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Hospitals and intensive care units, ambulatory surgical & diagnostic centers, nursing homes, and maternity centers, as well as other end users, make up the Hospital-acquired infection control market. The market revenue through the ambulatory surgery and diagnostic centers category is predicted to increase at a significant CAGR throughout the projection period.
The large contribution to the market revenue through ambulatory surgical and diagnostic centers is due to the rising prevalence of HAIs, and increasing acceptance of single-use medical devices in these healthcare facilities.
The key players in the market include Steris Plc, Sotera Health Company, Getinge AB, Advanced Sterilization Products, Ecolab Inc., 3M Company, Matachana Group, MMM Group, Belimed AG, and Reckitt Benckiser.
Some of the recent developments of key Hospital-acquired Infection Control providers are as follows:
Similarly, recent developments related to companies offering Hospital-acquired Infection Control have been tracked by the team at Future Market Insights, which is available in the full report.
Market analysts predict that by 2023 it may be worth US$ 6.5 billion.
Sales soared considerably at an HCAGR of 6.5% from 2018 to 2022.
Through 2033, the market is projected to maintain its momentum at a CAGR of 7%.
By 2033, it is expected that the size of the global market will approach US$ 12.7 billion.
The Asia Pacific market is scheduled to expand at a CAGR of 7% through 2033.
United Kingdom’s market is poised to develop at a CAGR of 5.8% through 2033.
1. Executive Summary 1.1. Global Market Outlook 1.2. Summary of Statistics 1.3. Key Market Characteristics & Attributes 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Risks and Trends Assessment 3.1. Risk Assessment 3.1.1. COVID-19 Crisis and Impact on District Cooling Demand 3.1.2. COVID-19 Impact Benchmark with Previous Crisis 3.1.3. Impact on Market Value (US$ Million) 3.1.4. Assessment by Key Countries 3.1.5. Assessment by Key Market Segments 3.1.6. Action Points and Recommendation for Suppliers 3.2. Key Trends Impacting the Market 3.3. Formulation and Product Development Trends 4. Market Background and Foundation Data Points 4.1. Global Market (US$ Million) 4.2. Market Opportunity Assessment (US$ Million) 4.2.1. Total Available Market 4.2.2. Serviceable Addressable Market 4.2.3. Serviceable Obtainable Market 4.3. Market Scenario Forecast 4.3.1. Demand in optimistic Scenario 4.3.2. Demand in Likely Scenario 4.3.3. Demand in Conservative Scenario 4.4. Investment Feasibility Analysis 4.4.1. Investment in Established Markets 4.4.1.1. In Short Term 4.4.1.2. In Long Term 4.4.2. Investment in Emerging Markets 4.4.2.1. In Short Term 4.4.2.2. In Long Term 4.5. Forecast Factors - Relevance & Impact 4.5.1. Top Companies Historical Growth 4.5.2. Global Market Growth 4.5.3. District Cooling Adoption Rate, By Country 4.6. Market Dynamics 4.6.1. Market Driving Factors and Impact Assessment 4.6.2. Prominent Market Challenges and Impact Assessment 4.6.3. Market Opportunities 4.6.4. Prominent Trends in the Global Market & Their Impact Assessment 5. Key Success Factors 5.1. Manufacturers’ Focus on Low Penetration High Growth Markets 5.2. Banking on with Segments High Incremental Opportunity 5.3. Peer Benchmarking 6. Global Market Demand Analysis 2018 to 2022 and Forecast, 2023 to 2033 6.1. Historical Market Analysis, 2018 to 2022 6.2. Current and Future Market Projections, 2023 to 2033 6.3. Y-o-Y Growth Trend Analysis 7. Global Market Value Analysis 2018 to 2022 and Forecast, 2023 to 2033 7.1. Historical Market Value (US$ Million) Analysis, 2018 to 2022 7.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033 7.2.1. Y-o-Y Growth Trend Analysis 7.2.2. Absolute $ Opportunity Analysis 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Component 8.1. Introduction / Key Findings 8.2. Historical Market Size (US$ Million) Analysis By Component, 2018 to 2022 8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Component, 2023 to 2033 8.3.1. Equipment 8.3.1.1. Sterilization Equipment 8.3.1.2. Disinfection Equipment 8.3.2. Consumables 8.3.2.1. Disinfectants 8.3.2.2. Sterilization Consumables 8.3.2.3. Others 8.3.3. Services 8.4. Market Attractiveness Analysis By Component 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-user 9.1. Introduction / Key Findings 9.2. Historical Market Size (US$ Million) Analysis By End-user, 2018 to 2022 9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By End-user, 2023 to 2033 9.3.1. Hospitals and Intensive Care Units 9.3.2. Ambulatory Surgical and Diagnostic Centers 9.3.3. Others 9.4. Market Attractiveness Analysis By End-user 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 10.1. Introduction 10.2. Historical Market Size (US$ Million) Analysis By Region, 2018 to 2022 10.3. Current Market Size (US$ Million) & Analysis and Forecast By Region, 2023 to 2033 10.3.1. North America 10.3.2. Latin America 10.3.3. Europe 10.3.4. Asia Pacific 10.3.5. Middle East and Africa (MEA) 10.4. Market Attractiveness Analysis By Region 11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 11.1. Introduction 11.2. Pricing Analysis 11.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033 11.4.1. By Country 11.4.1.1. USA 11.4.1.2. Canada 11.4.1.3. Rest of North America 11.4.2. By Component 11.4.3. By End-user 11.5. Market Attractiveness Analysis 11.5.1. By Country 11.5.2. By Component 11.5.3. By End-user 12. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033 12.1. Introduction 12.2. Pricing Analysis 12.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033 12.4.1. By Country 12.4.1.1. Brazil 12.4.1.2. Mexico 12.4.1.3. Rest of Latin America 12.4.2. By Component 12.4.3. By End-user 12.5. Market Attractiveness Analysis 12.5.1. By Country 12.5.2. By Component 12.5.3. By End-user 13. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033 13.1. Introduction 13.2. Pricing Analysis 13.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033 13.4.1. By Country 13.4.1.1. Germany 13.4.1.2. France 13.4.1.3. United kingdom 13.4.1.4. Italy 13.4.1.5. Benelux 13.4.1.6. Nordic Countries 13.4.1.7. Rest of Europe 13.4.2. By Component 13.4.3. By End-user 13.5. Market Attractiveness Analysis 13.5.1. By Country 13.5.2. By Component 13.5.3. By End-user 14. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033 14.1. Introduction 14.2. Pricing Analysis 14.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033 14.4.1. By Country 14.4.1.1. China 14.4.1.2. Japan 14.4.1.3. South Korea 14.4.1.4. Rest of Asia Pacific 14.4.2. By Component 14.4.3. By End-user 14.5. Market Attractiveness Analysis 14.5.1. By Country 14.5.2. By Component 14.5.3. By End-user 15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033 15.1. Introduction 15.2. Pricing Analysis 15.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033 15.4.1. By Country 15.4.1.1. GCC Countries 15.4.1.2. South Africa 15.4.1.3. Turkey 15.4.1.4. Rest of Middle East and Africa 15.4.2. By Component 15.4.3. By End-user 15.5. Market Attractiveness Analysis 15.5.1. By Country 15.5.2. By Component 15.5.3. By End-user 16. Key Countries Market Analysis 2018 to 2022 and Forecast 2023 to 2033 16.1. Introduction 16.1.1. Market Value Proportion Analysis, By Key Countries 16.1.2. Global Vs. Country Growth Comparison 16.2. US Market Analysis 16.2.1. Value Proportion Analysis by Market Taxonomy 16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.2.2.1. By Component 16.2.2.2. By End-user 16.3. Canada Market Analysis 16.3.1. Value Proportion Analysis by Market Taxonomy 16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.3.2.1. By Component 16.3.2.2. By End-user 16.4. Mexico Market Analysis 16.4.1. Value Proportion Analysis by Market Taxonomy 16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.4.2.1. By Component 16.4.2.2. By End-user 16.5. Brazil Market Analysis 16.5.1. Value Proportion Analysis by Market Taxonomy 16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.5.2.1. By Component 16.5.2.2. By End-user 16.6. Germany Market Analysis 16.6.1. Value Proportion Analysis by Market Taxonomy 16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.6.2.1. By Component 16.6.2.2. By End-user 16.7. France Market Analysis 16.7.1. Value Proportion Analysis by Market Taxonomy 16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.7.2.1. By Component 16.7.2.2. By End-user 16.8. Italy Market Analysis 16.8.1. Value Proportion Analysis by Market Taxonomy 16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.8.2.1. By Component 16.8.2.2. By End-user 16.9. BENELUX Market Analysis 16.9.1. Value Proportion Analysis by Market Taxonomy 16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.9.2.1. By Component 16.9.2.2. By End-user 16.10. UK Market Analysis 16.10.1. Value Proportion Analysis by Market Taxonomy 16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.10.2.1. By Component 16.10.2.2. By End-user 16.11. Nordic Countries Market Analysis 16.11.1. Value Proportion Analysis by Market Taxonomy 16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.11.2.1. By Component 16.11.2.2. By End-user 16.12. China Market Analysis 16.12.1. Value Proportion Analysis by Market Taxonomy 16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.12.2.1. By Component 16.12.2.2. By End-user 16.13. Japan Market Analysis 16.13.1. Value Proportion Analysis by Market Taxonomy 16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.13.2.1. By Component 16.13.2.2. By End-user 16.14. South Korea Market Analysis 16.14.1. Value Proportion Analysis by Market Taxonomy 16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.14.2.1. By Component 16.14.2.2. By End-user 16.15. GCC Countries Market Analysis 16.15.1. Value Proportion Analysis by Market Taxonomy 16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.15.2.1. By Component 16.15.2.2. By End-user 16.16. South Africa Market Analysis 16.16.1. Value Proportion Analysis by Market Taxonomy 16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.16.2.1. By Component 16.16.2.2. By End-user 16.17. Turkey Market Analysis 16.17.1. Value Proportion Analysis by Market Taxonomy 16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033 16.17.2.1. By Component 16.17.2.2. By End-user 16.17.3. Competition Landscape and Player Concentration in the Country 17. Market Structure Analysis 17.1. Market Analysis by Tier of Companies 17.2. Market Concentration 17.3. Market Share Analysis of Top Players 17.4. Market Presence Analysis 17.4.1. By Regional footprint of Players 17.4.2. Product footprint by Players 18. Competition Analysis 18.1. Competition Dashboard 18.2. Competition Benchmarking 18.3. Competition Deep Dive 18.3.1. Olympus Corporation 18.3.1.1. Overview 18.3.1.2. Product Portfolio 18.3.1.3. Sales Footprint 18.3.1.4. Strategy Overview 18.3.2. BD 18.3.2.1. Overview 18.3.2.2. Product Portfolio 18.3.2.3. Sales Footprint 18.3.2.4. Strategy Overview 18.3.3. Getinge AB 18.3.3.1. Overview 18.3.3.2. Product Portfolio 18.3.3.3. Sales Footprint 18.3.3.4. Strategy Overview 18.3.4. Xenex Disinfection Services Inc. 18.3.4.1. Overview 18.3.4.2. Product Portfolio 18.3.4.3. Sales Footprint 18.3.4.4. Strategy Overview 18.3.5. 3M 18.3.5.1. Overview 18.3.5.2. Product Portfolio 18.3.5.3. Sales Footprint 18.3.5.4. Strategy Overview 19. Assumptions and Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Hospital-acquired Infection Control Market
